These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10738735)

  • 1. [Neuroleptics and quality of life. A patient survey].
    Angermeyer MC; Matschinger H
    Psychiatr Prax; 2000 Mar; 27(2):64-8. PubMed ID: 10738735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attitude of family to neuroleptics].
    Angermeyer MC; Matschinger H
    Psychiatr Prax; 1999 Jul; 26(4):171-4. PubMed ID: 10457968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Rather overweight and mentally present...". Patients evaluate clozapine].
    Boitz K; Angermeyer MC; Löffler W; Müller P; Priebe S
    Psychiatr Prax; 1999 Jul; 26(4):188-93. PubMed ID: 10457971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
    Staring AB; Mulder CL; Duivenvoorden HJ; De Haan L; Van der Gaag M
    Schizophr Res; 2009 Aug; 113(1):27-33. PubMed ID: 19525092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' and relatives' assessment of clozapine treatment.
    Angermeyer MC; Löffler W; Müller P; Schulze B; Priebe S
    Psychol Med; 2001 Apr; 31(3):509-17. PubMed ID: 11305859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective experiences of clozapine treatment by patients with chronic schizophrenia.
    Waserman J; Criollo M
    Psychiatr Serv; 2000 May; 51(5):666-8. PubMed ID: 10783189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M; Scheel T; Eich FX
    J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viewpoint of schizophrenic patients: a European survey].
    Courtet P
    Encephale; 2001; 27(1):28-38. PubMed ID: 11294036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility decrements associated with side effects in schizophrenia.
    Millier A; Amri I; Boyer L; Auquier P; Toumi M
    J Med Econ; 2014 Dec; 17(12):853-61. PubMed ID: 25211094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients.
    Hertling I; Philipp M; Dvorak A; Glaser T; Mast O; Beneke M; Ramskogler K; Saletu-Zyhlarz G; Walter H; Lesch OM
    Neuropsychobiology; 2003; 47(1):37-46. PubMed ID: 12606844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics.
    Watanabe A; Shibata I; Kato T
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):268-73. PubMed ID: 15149292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics].
    Zaghdoudi L; Homri W; Belaid S; Ben Bechir M; Labbane R
    Tunis Med; 2009 Sep; 87(9):593-8. PubMed ID: 20180380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects of antipsychotics and quality of life].
    Mínguez Martín L; González Pablos E; Alonso del Teso F; Sanguino Andrés RM; García Alonso Y
    Actas Esp Psiquiatr; 2005; 33(1):1-6. PubMed ID: 15704024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
    Gharabawi GM; Greenspan A; Rupnow MF; Kosik-Gonzalez C; Bossie CA; Zhu Y; Kalali AH; Awad AG
    BMC Psychiatry; 2006 Oct; 6():45. PubMed ID: 17054789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.